Deep Track Capital LP 13D and 13G filings for Dyne Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 09:27 am Purchase | 2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN | Deep Track Capital LP | 3,282,000 3.270% | 1,282,000 (+64.10%) | Filing |
| 2024-02-14 08:39 am Sale | 2023-12-31 | 13G | Dyne Therapeutics, Inc. DYN | Deep Track Capital LP | 2,000,000 3.260% | -2,500,000 (-55.56%) | Filing |
| 2024-01-19 4:38 pm Purchase | 2024-01-11 | 13G | Dyne Therapeutics, Inc. DYN | Deep Track Capital LP | 4,500,000 5.550% | 2,500,000 (+125.00%) | Filing |
| 2024-01-19 09:08 am Sale | 2023-12-31 | 13G | Dyne Therapeutics, Inc. DYN | Deep Track Capital LP | 2,000,000 3.260% | -684,200 (-25.49%) | Filing |
| 2023-02-14 08:32 am Sale | 2022-12-31 | 13G | Dyne Therapeutics, Inc. DYN | Deep Track Capital LP | 2,684,200 5.150% | -132,750 (-4.71%) | Filing |
| 2022-01-20 4:27 pm Purchase | 2022-01-18 | 13G | Dyne Therapeutics, Inc. DYN | Deep Track Capital LP | 2,816,950 5.470% | 2,816,950 (New Position) | Filing |